Delivery Order SPE2DB20D3101-SPE2DB24FRSE0

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,449.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,394,098 units of Lidocaine 5% patches, with an ultimate completion date of August 12, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts to supply critical medical commodities, including prescription drugs, vaccines, and medical supplies,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,406.94 contract is for the supply of Lidocaine 5% Patches, a critical medical product used to treat pain. The order has a completion date of July 30, 2024. Amerisourcebergen is a prominent federal contractor, holding several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice valued at up to $999,999,999 and...
This is a $13,940.22 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4559407896 - Lidocaine 5% Patch 30s, a critical medical supply. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that enables the government to efficiently procure a comprehensive range of pharmaceutical and medical...
The Defense Logistics Agency (DLA) awarded a $1,213.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,229,968 units of Lidocaine 5% Patches. This contract has an ultimate completion date of July 24, 2024 and is not set aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,937.47 firm fixed-price delivery order is for the supply of 4560957153 - Lidocaine 5% Patch 30s, with a completion date of May 17, 2023. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $48,206.78 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,244,013 units of Lidocaine 5% Patch 30S. The contract has an ultimate completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these essential medical supplies to support military treatment facilities and federal healthcare programs. The contract award is not designated as a set-aside....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,428,053 units of Lidocaine 5% Patch 30s. The potential value of the award is $10,922.66, with a completion date of January 25, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA to provide a range of pharmaceutical products and medical supplies in...
The Defense Logistics Agency (DLA) awarded a $14,121.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,057,471 units of Lidocaine 5% patch. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,456,391 Lidocaine 5% Patch 30s. The contract has a ceiling value of $9,058.60 and a completion date of August 15, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts to supply a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $3,148.64 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of 4557487381 - Lidocaine 5% Patch 30s, a medical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that DLA awarded solely to Amerisourcebergen Drug Corp to provide a comprehensive...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRSE0
    Delivery Order

This is a $17,224.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565439642 - Lidocaine 5% Patch 30s. The award does not have a set-aside designation and has an ultimate completion date of August 14, 2024. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of pharmaceuticals and medical supplies, including critical care materials and medications across various therapeutic areas. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/12/24, 9:03 AM